Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observtion in Treating Patients with High Risk Uterine Leiomyosarcoma Previously removed by Surgery
Trial Number
NCT01533207 (ClinicalTrials.gov Identifier)Contact Person
Status
Completed
Disease Site
Uterine Leiomyosarcoma
Lead Cooperative Group
Participating Groups
SGCTG